Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation

The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non‐small‐cell lung cancer cell line (H460) and one normal pr...

Full description

Saved in:
Bibliographic Details
Published inChembiochem : a European journal of chemical biology Vol. 23; no. 18; pp. e202200259 - n/a
Main Authors Azmanova, Maria, Rafols, Laia, Cooper, Patricia A., Seaton, Colin C., Shnyder, Steven D., Pitto‐Barry, Anaïs
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 16.09.2022
Wiley-VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non‐small‐cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18‐electron complexes were designed with four water‐soluble phosphine ligands to increase the water‐solubility character of the corresponding electron‐deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine‐3,3′,3′′‐trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16‐electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay. Phosphine ligands are coordinated to [(η6‐p‐cymene)Ru(maleonitriledithiolate)] to obtain ruthenium(II) complexes with different hydrophilicities. Characterisation and evaluation of the in vitro cytotoxicity towards two ovarian, one non‐small‐cell lung cancer cell lines and one normal prostate cell line are presented. A mechanism of action based on reactive oxygen species production leading to apoptosis is suggested. In vivo evaluation suggests some evidence of tumour growth delay.
AbstractList The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate-based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non-small-cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18-electron complexes were designed with four water-soluble phosphine ligands to increase the water-solubility character of the corresponding electron-deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine-3,3',3''-trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16-electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay.The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate-based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non-small-cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18-electron complexes were designed with four water-soluble phosphine ligands to increase the water-solubility character of the corresponding electron-deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine-3,3',3''-trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16-electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay.
The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non‐small‐cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18‐electron complexes were designed with four water‐soluble phosphine ligands to increase the water‐solubility character of the corresponding electron‐deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine‐3,3′,3′′‐trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16‐electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay.
The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non‐small‐cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18‐electron complexes were designed with four water‐soluble phosphine ligands to increase the water‐solubility character of the corresponding electron‐deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine‐3,3′,3′′‐trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16‐electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay. Phosphine ligands are coordinated to [(η6‐p‐cymene)Ru(maleonitriledithiolate)] to obtain ruthenium(II) complexes with different hydrophilicities. Characterisation and evaluation of the in vitro cytotoxicity towards two ovarian, one non‐small‐cell lung cancer cell lines and one normal prostate cell line are presented. A mechanism of action based on reactive oxygen species production leading to apoptosis is suggested. In vivo evaluation suggests some evidence of tumour growth delay.
The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various phosphine ligands towards two ovarian cancer cell lines (A2780 and A2780cisR), one non‐small‐cell lung cancer cell line (H460) and one normal prostate cell line (PNT2) are presented herein. These 18‐electron complexes were designed with four water‐soluble phosphine ligands to increase the water‐solubility character of the corresponding electron‐deficient ruthenium complex which showed great in vitro promises, and triphenylphosphine for comparison. The complexes with triphenylphosphine‐3,3′,3′′‐trisulfonic acid and triphenylphosphine present similar cytotoxicity compared to the 16‐electron precursor, with equal cytotoxicity to both A2780 and A2780cisR. Hints at the mechanism of action suggest an apoptotic pathway based on reactive oxygen species (ROS) production. No toxicity was observed in preliminary in vivo pilot studies for these two complexes in subcutaneous A2780 and A2780cisR xenograft models, with some evidence of tumour growth delay.
Author Azmanova, Maria
Seaton, Colin C.
Shnyder, Steven D.
Pitto‐Barry, Anaïs
Cooper, Patricia A.
Rafols, Laia
Author_xml – sequence: 1
  givenname: Maria
  orcidid: 0000-0002-6800-3772
  surname: Azmanova
  fullname: Azmanova, Maria
  organization: University of Bradford
– sequence: 2
  givenname: Laia
  orcidid: 0000-0002-2159-9636
  surname: Rafols
  fullname: Rafols, Laia
  organization: University of Bradford
– sequence: 3
  givenname: Patricia A.
  orcidid: 0000-0002-6875-0313
  surname: Cooper
  fullname: Cooper, Patricia A.
  organization: University of Bradford
– sequence: 4
  givenname: Colin C.
  surname: Seaton
  fullname: Seaton, Colin C.
  organization: University of Bradford
– sequence: 5
  givenname: Steven D.
  orcidid: 0000-0002-4647-2340
  surname: Shnyder
  fullname: Shnyder, Steven D.
  organization: University of Bradford
– sequence: 6
  givenname: Anaïs
  orcidid: 0000-0001-5100-0922
  surname: Pitto‐Barry
  fullname: Pitto‐Barry, Anaïs
  email: anais.pitto-barry@universite-paris-saclay.fr
  organization: University of Bradford
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35838006$$D View this record in MEDLINE/PubMed
https://cnrs.hal.science/hal-03752249$$DView record in HAL
BookMark eNqFkc1uEzEUhS1URH9gyxKNxAYWCf6ZGcfswqjQSpGKVBASG8v2XFNXHjvYM4XseASekSfBIWmRKiFWtq-_c659zzE6CDEAQk8JnhOM6SujnZlTTGk5NOIBOiI1EzPeMnaw39eU8kN0nPM1xli0jDxCh6xZsAXG7RH6vAyjMyoYSNUnNUL69ePnZfST9lBdpC8qxDSNVxDcNFRdHNYevkN-XV1uQqlmlysV-up9AuNdKD6-Or1RflKji-ExemiVz_Bkv56gj29PP3Rns9XFu_NuuZqZuuZipqnFlLc9MFUe1Qi9MEJYQSz0tilXxHLCCG3awvBCad3qheVWgwCtes1O0Mud75Xycp3coNJGRuXk2XIltzXMeENpLW5IYV_s2HWKXyfIoxxcNuC9ChCnLGkrCG64EKygz--h13FKofxEUk7qpm1Iywv1bE9NeoD-rv_thAtQ7wCTYs4JrDRu_DOfMSnnJcFyG6TcBinvgiyy-T3ZrfM_BWIn-OY8bP5Dy-7NefdX-xtMRbDs
CitedBy_id crossref_primary_10_1002_cplu_202400621
crossref_primary_10_1039_D4MD00306C
crossref_primary_10_1002_hlca_202300064
Cites_doi 10.1016/j.poly.2019.02.041
10.1021/ar9502341
10.1039/C9CC01974J
10.3390/M1025
10.1246/cl.190179
10.1002/ejic.200700112
10.1002/cmdc.201900528
10.1021/acsami.8b01776
10.1039/C6DT00668J
10.1039/D0SC00897D
10.1039/C8MT00072G
10.1021/acsomega.8b02154
10.1155/2015/673512
10.1021/acs.jmedchem.8b00958
10.1016/S0022-328X(00)00345-4
10.1002/chem.200901939
10.1038/s41416-020-0926-3
10.1002/anie.201912219
10.1002/cbic.201900236
10.1016/j.inoche.2007.07.023
10.1080/10426509008045879
10.1039/C7DT02827J
10.1021/jacs.1c13137
10.3390/molecules26051390
10.1002/cmdc.202000096
10.1021/om2012425
10.1016/j.ejmech.2019.112030
10.1002/cmdc.202000672
10.1021/om900483t
10.1016/j.ccr.2021.213950
10.1039/C5DT04398K
10.3390/molecules25194540
10.1016/j.jorganchem.2010.11.009
10.1016/j.molcata.2003.01.001
10.1039/C8DT01232F
10.1002/ejic.201501458
10.1002/ange.201912219
ContentType Journal Article
Copyright 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH
2022 The Authors. ChemBioChem published by Wiley-VCH GmbH.
2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Attribution
Copyright_xml – notice: 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH
– notice: 2022 The Authors. ChemBioChem published by Wiley-VCH GmbH.
– notice: 2022. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Attribution
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QO
7TM
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
1XC
VOOES
DOI 10.1002/cbic.202200259
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Virology and AIDS Abstracts
Biotechnology Research Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
CrossRef

Virology and AIDS Abstracts
MEDLINE

Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1439-7633
EndPage n/a
ExternalDocumentID oai_HAL_hal_03752249v1
35838006
10_1002_cbic_202200259
CBIC202200259
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Royal Society
  funderid: URF150295; RGF\EA\201001
– fundername: Academy of Medical Sciences/the Wellcome Trust/the Government Department of Business, Energy and Industrial/the British Heart Foundation Springboard Award
  funderid: SBF003\1170
– fundername: Wellcome Trust
– fundername: British Heart Foundation
  grantid: SBF003\1170
GroupedDBID ---
-DZ
-~X
05W
0R~
1L6
1OC
24P
29B
33P
3WU
4.4
4ZD
50Y
5GY
5VS
66C
6J9
6P2
77Q
8-0
8-1
8UM
A00
AAESR
AAHHS
AAHQN
AAIHA
AAMNL
AANLZ
AAXRX
AAYCA
AAZKR
ABCUV
ABIJN
ABJNI
ABLJU
ACAHQ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMYDB
AZVAB
BDRZF
BFHJK
BMXJE
BRXPI
CS3
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EMOBN
F5P
G-S
GNP
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
JPC
KQQ
LATKE
LAW
LEEKS
LITHE
LOXES
LUTES
LYRES
MEWTI
MXFUL
MXSTM
MY~
NNB
O9-
OIG
P2P
P2W
P4E
PQQKQ
R.K
ROL
RWI
RX1
SUPJJ
SV3
V2E
W99
WBKPD
WH7
WJL
WOHZO
WXSBR
WYJ
XPP
XV2
Y6R
YZZ
ZZTAW
~KM
~S-
AAYXX
AEYWJ
AGHNM
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QO
7TM
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
.GJ
1XC
31~
53G
AANHP
AASGY
ACBWZ
ACRPL
ACYXJ
ADNMO
AFFNX
AGQPQ
AI.
ASPBG
AVWKF
AZFZN
EJD
FEDTE
GODZA
HVGLF
VH1
VOOES
XSW
ZGI
ID FETCH-LOGICAL-c4479-b2f0276de3a83859b8c99f91fedf5f021f713125676d7de3bb6b8f7fbe9ebadb3
IEDL.DBID DR2
ISSN 1439-4227
1439-7633
IngestDate Fri May 09 12:20:24 EDT 2025
Fri Jul 11 10:15:24 EDT 2025
Fri Jul 25 12:10:03 EDT 2025
Mon Jul 21 05:57:35 EDT 2025
Tue Jul 01 04:35:22 EDT 2025
Thu Apr 24 23:03:26 EDT 2025
Wed Jan 22 16:23:53 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 18
Keywords in vivo evaluation
half-sandwich complexes
metallodrugs
phosphine ligands
bioinorganic chemistry
phosphines
ligands
antineoplastic agents
drug screening assays
in vivo evaluation
lung neoplasms
antitumor
water
organophosphorus compounds
ovarian neoplasms
ruthenium
carcinoma
tumor
reactive oxygen species
non-small-cell lung
female
coordination complexes
humans
cell line
Language English
License Attribution
2022 The Authors. ChemBioChem published by Wiley-VCH GmbH.
Attribution: http://creativecommons.org/licenses/by
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4479-b2f0276de3a83859b8c99f91fedf5f021f713125676d7de3bb6b8f7fbe9ebadb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2159-9636
0000-0002-6875-0313
0000-0002-6800-3772
0000-0001-5100-0922
0000-0002-4647-2340
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcbic.202200259
PMID 35838006
PQID 2714565167
PQPubID 986344
PageCount 10
ParticipantIDs hal_primary_oai_HAL_hal_03752249v1
proquest_miscellaneous_2691057993
proquest_journals_2714565167
pubmed_primary_35838006
crossref_citationtrail_10_1002_cbic_202200259
crossref_primary_10_1002_cbic_202200259
wiley_primary_10_1002_cbic_202200259_CBIC202200259
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 16, 2022
PublicationDateYYYYMMDD 2022-09-16
PublicationDate_xml – month: 09
  year: 2022
  text: September 16, 2022
  day: 16
PublicationDecade 2020
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Weinheim
PublicationTitle Chembiochem : a European journal of chemical biology
PublicationTitleAlternate Chembiochem
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
Wiley-VCH Verlag
Publisher_xml – name: Wiley Subscription Services, Inc
– name: Wiley-VCH Verlag
References 2021; 26
2011; 696
2019; 55
2019; 2
2021; 445
2017; 46
2019; 14
2020; 15
2007
2020; 188
2020; 123
2020; 11
2018; 61
2007; 10
2012; 31
2019 2019; 58 131
2018; 47
2009; 28
2022; 144
2000; 607
2021; 16
2018; 3
2018; 2018
2004; 215
2019; 20
1990; 48
1997; 30
2019; 48
2015; 2015
2020; 25
2016
2018; 10
2019; 172
2009; 15
2016; 45
e_1_2_10_23_1
e_1_2_10_45_2
e_1_2_10_46_1
e_1_2_10_24_1
e_1_2_10_44_2
e_1_2_10_20_2
e_1_2_10_20_3
e_1_2_10_21_2
e_1_2_10_22_1
e_1_2_10_43_1
e_1_2_10_42_1
e_1_2_10_41_1
e_1_2_10_1_1
e_1_2_10_2_1
e_1_2_10_3_2
e_1_2_10_17_2
e_1_2_10_18_2
e_1_2_10_19_1
e_1_2_10_39_2
e_1_2_10_16_1
e_1_2_10_38_2
Wang X. (e_1_2_10_40_1) 2019; 2
e_1_2_10_4_2
e_1_2_10_5_1
e_1_2_10_7_2
e_1_2_10_13_2
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_6_2
e_1_2_10_15_1
e_1_2_10_36_1
e_1_2_10_9_2
e_1_2_10_35_1
e_1_2_10_8_2
e_1_2_10_12_2
e_1_2_10_34_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_31_1
e_1_2_10_30_1
e_1_2_10_28_2
e_1_2_10_29_1
e_1_2_10_27_2
e_1_2_10_25_1
e_1_2_10_26_1
References_xml – volume: 607
  start-page: 203
  year: 2000
  end-page: 207
  publication-title: J. Organomet. Chem.
– volume: 58 131
  start-page: 18482 18653
  year: 2019 2019
  end-page: 18486 18657
  publication-title: Angew. Chem. Int. Ed. Angew. Chem.
– volume: 696
  start-page: 989
  year: 2011
  end-page: 998
  publication-title: J. Organomet. Chem.
– volume: 172
  start-page: 22
  year: 2019
  end-page: 27
  publication-title: Polyhedron
– volume: 3
  start-page: 15623
  year: 2018
  end-page: 15627
  publication-title: ACS Omega
– start-page: 2926
  year: 2007
  end-page: 2933
  publication-title: Eur. J. Inorg. Chem.
– volume: 10
  start-page: 696
  year: 2018
  end-page: 712
  publication-title: Metallomics
– volume: 31
  start-page: 756
  year: 2012
  end-page: 767
  publication-title: Organometallics
– volume: 144
  start-page: 4091
  year: 2022
  end-page: 4101
  publication-title: J. Am. Chem. Soc.
– volume: 10
  start-page: 13693
  year: 2018
  end-page: 13701
  publication-title: ACS Appl. Mater. Interfaces
– volume: 25
  start-page: 4540
  year: 2020
  publication-title: Molecules
– start-page: 1267
  year: 2016
  end-page: 1273
  publication-title: Eur. J. Inorg. Chem.
– volume: 10
  start-page: 1222
  year: 2007
  end-page: 1225
  publication-title: Inorg. Chem. Commun.
– volume: 215
  start-page: 23
  year: 2004
  end-page: 32
  publication-title: J. Mol. Catal. A
– volume: 16
  start-page: 624
  year: 2021
  end-page: 629
  publication-title: ChemMedChem
– volume: 48
  start-page: 37
  year: 1990
  end-page: 40
  publication-title: Phosphor. Sulfur Silicon Related Elements
– volume: 48
  start-page: 916
  year: 2019
  end-page: 924
  publication-title: Chem. Lett.
– volume: 61
  start-page: 9246
  year: 2018
  end-page: 9255
  publication-title: J. Med. Chem.
– volume: 20
  start-page: 2876
  year: 2019
  end-page: 2882
  publication-title: ChemBioChem
– volume: 28
  start-page: 4249
  year: 2009
  end-page: 4251
  publication-title: Organometallics
– volume: 26
  start-page: 1390
  year: 2021
  publication-title: Molecules
– volume: 445
  year: 2021
  publication-title: Coord. Chem. Rev.
– volume: 14
  start-page: 1887
  year: 2019
  end-page: 1893
  publication-title: ChemMedChem
– volume: 46
  start-page: 15676
  year: 2017
  end-page: 15683
  publication-title: Dalton Trans.
– volume: 55
  start-page: 6038
  year: 2019
  end-page: 6041
  publication-title: Chem. Commun.
– volume: 2
  start-page: 141
  year: 2019
  end-page: 160
  publication-title: Cancer Drug Resistance
– volume: 15
  start-page: 982
  year: 2020
  end-page: 987
  publication-title: ChemMedChem
– volume: 47
  start-page: 7290
  year: 2018
  end-page: 7299
  publication-title: Dalton Trans.
– volume: 45
  start-page: 1763
  year: 2016
  end-page: 1768
  publication-title: Dalton Trans.
– volume: 123
  start-page: 871
  year: 2020
  end-page: 873
  publication-title: Br. J. Cancer
– volume: 2018
  start-page: M1025
  year: 2018
  publication-title: Molbank
– volume: 45
  start-page: 11791
  year: 2016
  end-page: 11800
  publication-title: Dalton Trans.
– volume: 11
  start-page: 5466
  year: 2020
  end-page: 5480
  publication-title: Chem. Sci.
– volume: 15
  start-page: 12283
  year: 2009
  end-page: 12291
  publication-title: Chem. Eur. J.
– volume: 2015
  year: 2015
  publication-title: BioMed Res. Int.
– volume: 30
  start-page: 97
  year: 1997
  end-page: 102
  publication-title: Acc. Chem. Res.
– volume: 188
  year: 2020
  publication-title: Eur. J. Med. Chem.
– ident: e_1_2_10_8_2
  doi: 10.1016/j.poly.2019.02.041
– ident: e_1_2_10_12_2
  doi: 10.1021/ar9502341
– ident: e_1_2_10_21_2
  doi: 10.1039/C9CC01974J
– ident: e_1_2_10_28_2
  doi: 10.3390/M1025
– ident: e_1_2_10_5_1
– ident: e_1_2_10_9_2
  doi: 10.1246/cl.190179
– ident: e_1_2_10_2_1
– ident: e_1_2_10_32_1
  doi: 10.1002/ejic.200700112
– ident: e_1_2_10_22_1
  doi: 10.1002/cmdc.201900528
– ident: e_1_2_10_17_2
  doi: 10.1021/acsami.8b01776
– ident: e_1_2_10_36_1
  doi: 10.1039/C6DT00668J
– ident: e_1_2_10_6_2
  doi: 10.1039/D0SC00897D
– ident: e_1_2_10_3_2
  doi: 10.1039/C8MT00072G
– ident: e_1_2_10_18_2
  doi: 10.1021/acsomega.8b02154
– ident: e_1_2_10_42_1
  doi: 10.1155/2015/673512
– ident: e_1_2_10_43_1
– ident: e_1_2_10_45_2
  doi: 10.1021/acs.jmedchem.8b00958
– ident: e_1_2_10_10_1
  doi: 10.1016/S0022-328X(00)00345-4
– ident: e_1_2_10_39_2
  doi: 10.1002/chem.200901939
– ident: e_1_2_10_16_1
– ident: e_1_2_10_19_1
– ident: e_1_2_10_4_2
  doi: 10.1038/s41416-020-0926-3
– ident: e_1_2_10_20_2
  doi: 10.1002/anie.201912219
– ident: e_1_2_10_26_1
– ident: e_1_2_10_7_2
  doi: 10.1002/cbic.201900236
– ident: e_1_2_10_25_1
  doi: 10.1016/j.inoche.2007.07.023
– ident: e_1_2_10_31_1
  doi: 10.1080/10426509008045879
– ident: e_1_2_10_15_1
  doi: 10.1039/C7DT02827J
– ident: e_1_2_10_37_1
– ident: e_1_2_10_46_1
  doi: 10.1021/jacs.1c13137
– ident: e_1_2_10_30_1
  doi: 10.3390/molecules26051390
– volume: 2
  start-page: 141
  year: 2019
  ident: e_1_2_10_40_1
  publication-title: Cancer Drug Resistance
– ident: e_1_2_10_23_1
  doi: 10.1002/cmdc.202000096
– ident: e_1_2_10_1_1
– ident: e_1_2_10_13_2
  doi: 10.1021/om2012425
– ident: e_1_2_10_44_2
  doi: 10.1016/j.ejmech.2019.112030
– ident: e_1_2_10_24_1
  doi: 10.1002/cmdc.202000672
– ident: e_1_2_10_38_2
  doi: 10.1021/om900483t
– ident: e_1_2_10_41_1
  doi: 10.1016/j.ccr.2021.213950
– ident: e_1_2_10_14_1
  doi: 10.1039/C5DT04398K
– ident: e_1_2_10_27_2
  doi: 10.3390/molecules25194540
– ident: e_1_2_10_35_1
  doi: 10.1016/j.jorganchem.2010.11.009
– ident: e_1_2_10_33_1
  doi: 10.1016/j.molcata.2003.01.001
– ident: e_1_2_10_29_1
  doi: 10.1039/C8DT01232F
– ident: e_1_2_10_34_1
  doi: 10.1002/ejic.201501458
– ident: e_1_2_10_11_1
– ident: e_1_2_10_20_3
  doi: 10.1002/ange.201912219
SSID ssj0009631
Score 2.3876262
Snippet The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various...
The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate‐based ruthenium metal complexes bearing various...
The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate-based ruthenium metal complexes bearing various...
The synthesis, characterisation, and evaluation of the in vitro cytotoxicity of five maleonitriledithiolate-based ruthenium metal complexes bearing various...
SourceID hal
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e202200259
SubjectTerms Antineoplastic Agents - pharmacology
Apoptosis
Biocompatibility
bioinorganic chemistry
Cancer
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Chemical Sciences
Coordination Complexes - toxicity
Coordination compounds
Cytotoxicity
Drug Screening Assays, Antitumor
Female
half-sandwich complexes
Humans
In vivo methods and tests
in vivo evaluation
Life Sciences
Ligands
Lung cancer
Lung Neoplasms
Medicinal Chemistry
Metal complexes
metallodrugs
Organophosphorus Compounds
Organoruthenium complexes
Ovarian cancer
Ovarian Neoplasms
Phosphine
phosphine ligands
Phosphines
Prostate
Prostate cancer
Reactive Oxygen Species
Ruthenium
Ruthenium - pharmacology
Ruthenium compounds
Synthesis
Toxicity
Tumor cell lines
Tumors
Water
Xenografts
Xenotransplantation
Title Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcbic.202200259
https://www.ncbi.nlm.nih.gov/pubmed/35838006
https://www.proquest.com/docview/2714565167
https://www.proquest.com/docview/2691057993
https://cnrs.hal.science/hal-03752249
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RXuBCoeWRUiqDEJzSNo7zcG_LqtWCAFVARcUlshNbrLr1VptdRDnxE_ob-SXMOI-yIIQEtzzGipOMx9-Mx98APCkrXhmTJKFI0ASK3MSh4taGBqdKbJFL4wP6r9-ko2Px8iQ5-WkXf8MP0QfcaGR4e00DXOl694o0tNRjoiDklGWQ0A4-StgiVPT2ij8Ktct7XIKWOznPOtbGPb673HxpVlr5RDmRvwPOZfzqJ6DDNVBd15u8k9OdxVzvlF9_YXX8n3e7BTdbdMoGjTrdhmvGrcPGwKFnfnbBnjKfL-oD8etwfdjVituAjwNHMXFUoBn7gOh19v3bJQXc9MQwv9tzOqNMejdenDGyQBPzxdT77N2Fw6v1uGbKVewIjW-7T5Md9CTkd-D48OD9cBS2VRvCUohMhppbdHXTysQqj_NE6ryU0srImsomeCuy6BcjrEpRJkMprVOd28xqI41WlY7vwqqbOnMfWJRYq6o0RUhRiTxWWnGZl-iQJnsqEyYOIOz-WlG2lOZUWWNSNGTMvKAPWfQfMoBnvfx5Q-bxR8nHqAS9EHFwjwavCrpGRYMR98jPUQBbnY4U7civC55FBJKjNAvgUX8bfwctxChnpguUSSWVV0ZoGMC9Rrf6R8W0jo2mMADuNeQvHS2Gz18M-7PNf2n0AG7QMSXBROkWrM5nC_MQkdZcb8MKF0fbfkz9AKhJIJI
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LTxRBEK4AHvCCCiojqK3xcRpgep5t4mFdILuyEKMQiZexe6Y7blxmyc6uup78Cf4V_wo_gV9i1bzIaoyJCQeP01Pz7Hp39VcAj5KUp1r7vu35qAK9SLu25MbYGk0lXhEJXST09w-CzpH38tg_noMf9V6YEh-iSbiRZBT6mgScEtKbF6ihieoTBiGnMgNfVHWVe3r6GaO2_Hl3G6f4Mee7O4ftjl01FrATzwuFrbjBaCxItSsjN_KFihIhjHCMTo2PpxyDoRta_gBpQqRSKlCRCY3SQiuZKhfvOw9XqI04wfVvv75ArEJ-LmI8jxZYOQ9rnMgtvjn7vjN2cP4DVWH-7uLOesyFydu9Bmf1zyorXT5uTMZqI_n6C47kf_U3r8NS5YCzVikxN2BOZ8uw0srkeHgyZU9YURJbrDUsw2K7boe3Au9aGaX9UUZG7C066KPzb98pp6gGmhUbWocj2iyQ9ScnjJTsQH_R-TP2ZprhaN7PmcxS9grtS7UVle00OOs34ehSvvgWLGTDTK8Cc3xjZBoE6DWlXuRKJbmIEoy5_S0Zetq1wK7ZJE4q1HZqHjKIS7xpHtPExc3EWfC0oT8t8Ur-SPkQua4hIpjxTqsX0xj1RUbXTnxyLFivmTKulFse89ChOMAJQgseNKdxOmitSWZ6OEGaQFAHafR-LbhdMnPzKJeW6lHbW8ALlvzLi8btF912c3TnXy66D4udw_1e3Ose7K3BVRqnmh8nWIeF8Wii76JjOVb3ClFm8P6yuf0nOCWANA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB61RQIuCFp-UgoYxM8pauMkTozEYdl2tUtLtRJUVL2YOLHVlbbZatNt2RuP0EfpM_EkzOSvWiGEhNRjnEliZezxN-PxNwCv04xnxoShG4RoAoPY-G7CrXUNLpX4RCxNGdD_vC_6B8Gnw_BwCa6aszAVP0QbcKOZUdprmuCnmd28Jg1N9YgoCDllGYSyTqvcNfMLdNqKD4Nt1PAbzns7X7t9t64r4KZBEElXc4vOmMiMn8R-HEodp1Ja6VmT2RBveRY9N1z4BcpEKKW10LGNrDbS6CTTPr53GW7RDiMlkfFgeE3zK8oKiAhCpBtwHjU0kVt8c7G_C8vg8jElYf6JcBcBc7ni9e7DvRqqsk41th7AkslXYa2To5t-MmdvWZk8WkblV-FOtykctwZHnZwC5DiapuwbQtnpr5-XFH3TY8PKo5-TKaXV56PZCSNzNDY_TPGefZnn2FqMCpbkGRuiJa4PbbKdlpH8IRzcyK9-BCv5JDdPgHmhtUkmBOKLLIj9RCdcxil6p-FWEgXGd8Bt_qhKa35zKrMxVhUzM1ekAdVqwIF3rfxpxezxV8lXqKBWiAi5-509RW1UQRhBkDz3HNho9KdqM1AoHnmEmD0ROfCyvY3qoF2ZJDeTGcoISbWWESc68LjSe_spnza10S46wMuB8I-Oqu7HQbe9Wv-fh17A7eF2T-0N9nefwl1qpuQYT2zAytl0Zp4hAjvTz8tBz-D7Tc-y30hAPLk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anticancer+Water%E2%80%90Soluble+Organoruthenium+Complexes%3A+Synthesis+and+Preclinical+Evaluation&rft.jtitle=Chembiochem+%3A+a+European+journal+of+chemical+biology&rft.au=Azmanova%2C+Maria&rft.au=Rafols%2C+Laia&rft.au=Cooper%2C+Patricia+A&rft.au=Seaton%2C+Colin+C&rft.date=2022-09-16&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1439-4227&rft.eissn=1439-7633&rft.volume=23&rft.issue=18&rft_id=info:doi/10.1002%2Fcbic.202200259&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1439-4227&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1439-4227&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1439-4227&client=summon